Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Paclitaxel Micelles for Injection
DRUG
2 trials
Sponsors
Shanghai Yizhong Pharmaceutical Co., Ltd.
, First Affiliated Hospital of Zhejiang University
Conditions
Advanced Solid Tumors
Non-Small Cell Lung Cancer(NSCLC)
Phase 1
Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.
Recruiting
NCT04778839
First Affiliated Hospital of Zhejiang University
Advanced Solid Tumors
Start: 2021-03-04
End: 2026-06-30
Target: 98
Updated: 2025-08-06
Phase 3
Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC
NCT02667743
Shanghai Yizhong Pharmaceutical Co., Ltd.
Non-Small Cell Lung Cancer(NSCLC)
Start: 2015-05-31
End: 2021-12-31
Updated: 2021-03-17
Related Papers
Polymeric micellar paclitaxel (Pm-Pac) prolonged overall survival for NSCLC patients without pleural metastasis.
2022-06-25
13 citations
Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial
Annals of Oncology
2020-10-30
69 citations